Herrera Malpica Wilmer Santiago, Gómez Jully C, Ortiz-Corredor Fernando, Hernández Paula Vanessa Muñetones, Correa-Arrieta Cristian
Physical Medicine and Rehabilitation Department, Universidad Nacional de Colombia, Bogotá, Colombia.
Clinical Neurologist, Universidad De Sabana, Bogotá, Colombia.
Acta Myol. 2025 Jun;44(2):57-61. doi: 10.36185/2532-1900-1028.
Bethlem myopathy (BM) is a collagen-VI-related myopathy caused by mutations in the COL6A1, COL6A2, and COL6A3 genes. It is characterized by proximal muscle weakness, distal joint laxity, and contractures, with symptoms appearing during childhood and progressing slowly. Muscle ultrasound, using tools like the Heckmatt scale, complements genetic analysis and provides noninvasive insights into muscle pathology, particularly in atypical presentations.
An 8-year-old male presented with muscle weakness since birth, delayed motor milestones, toe walking, and frequent falls. Family history revealed maternal-line neuromuscular disorders. Clinical examination showed hyporeflexia, thoracic hypotrophy, and decreased proximal muscle strength, alongside joint hypermobility and keratosis pilaris. Electromyography indicated a myopathic pattern in proximal upper limb muscles. Genetic analysis confirmed a pathogenic COL6A1 variant (c.788G > A, p.Gly263Asp). Ultrasound findings revealed advanced structural compromise with Heckmatt grade IV echogenicity in the deltoid, iliopsoas, and rectus femoris, indicating fatty infiltration and fibrosis. Functional tests, including Motor Function Measurement (MFM), showed adequate performance despite significant structural abnormalities.
This case illustrates the diagnostic challenges of BM, characterized by phenotypic variability and the complexity of correlating structural and functional findings. Muscle ultrasound findings demonstrated advanced echogenic changes, but functional performance remained preserved, highlighting a mismatch between structural changes and functional outcomes.
This case highlights the diagnostic challenges of BM, where a patient with a COL6A1 gene mutation exhibited significant muscle abnormalities on ultrasound but maintained relatively preserved motor function according to the MFM scale. This discrepancy emphasizes the limitations of functional assessments like MFM in capturing the extent of muscle weakness. Ultrasound and dynamometry provided a more comprehensive evaluation, underscoring the importance of integrating structural and functional assessments for accurate diagnosis and management. This case stresses the need for an individualized approach in managing BM, considering both genetic and clinical findings.
贝斯勒肌病(BM)是一种由COL6A1、COL6A2和COL6A3基因突变引起的与胶原蛋白VI相关的肌病。其特征为近端肌无力、远端关节松弛和挛缩,症状在儿童期出现并缓慢进展。肌肉超声检查,如使用赫克马特量表等工具,可辅助基因分析,并提供对肌肉病理学的无创性见解,尤其是在非典型表现中。
一名8岁男性自出生以来就出现肌无力、运动发育迟缓、足尖行走和频繁跌倒。家族史显示母系存在神经肌肉疾病。临床检查发现反射减退、胸廓萎缩、近端肌力下降,同时伴有关节活动过度和毛发角化病。肌电图显示近端上肢肌肉呈肌病模式。基因分析证实存在致病性COL6A1变异(c.788G > A,p.Gly263Asp)。超声检查结果显示三角肌、髂腰肌和股直肌出现严重的结构破坏,赫克马特回声分级为IV级,提示脂肪浸润和纤维化。包括运动功能测量(MFM)在内的功能测试表明,尽管存在明显的结构异常,但患者表现尚可。
本病例说明了BM的诊断挑战,其特点是表型变异性以及结构和功能结果相关性的复杂性。肌肉超声检查结果显示存在严重的回声改变,但功能表现仍得以保留,突出了结构变化与功能结果之间的不匹配。
本病例突出了BM的诊断挑战,一名COL6A1基因突变患者超声检查显示存在明显的肌肉异常,但根据MFM量表其运动功能相对保留。这种差异强调了MFM等功能评估在评估肌无力程度方面的局限性。超声检查和肌力测量提供了更全面的评估,强调了整合结构和功能评估以进行准确诊断和管理的重要性。本病例强调了在管理BM时需要采取个体化方法,同时考虑基因和临床结果。